Biotechnology Companies By Shares Shorted

LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Number Of Shares Shorted
Return On Equity
Return On Asset
Profit Margin
Operating Margin
Current Valuation
Shares Outstanding
Shares Owned By Insiders
Shares Owned By Institutions
Number Of Shares Shorted
Price To Earning
Price To Book
Price To Sales
Revenue
Gross Profit
EBITDA
Net Income
Cash And Equivalents
Cash Per Share
Total Debt
Debt To Equity
Current Ratio
Book Value Per Share
Cash Flow From Operations
Short Ratio
Earnings Per Share
Price To Earnings To Growth
Target Price
Number Of Employees
Beta
Market Capitalization
Total Asset
Retained Earnings
Working Capital
Current Asset
Current Liabilities
Number Of Shares ShortedEfficiencyMarket RiskExp Return
1RXRX Recursion Pharmaceuticals
94.52 M
(0.02)
 7.19 
(0.18)
2IOVA Iovance Biotherapeutics
71.37 M
(0.13)
 5.06 
(0.66)
3OCGN Ocugen Inc
68.67 M
 0.04 
 5.73 
 0.20 
4IBRX Immunitybio
67.18 M
(0.05)
 6.22 
(0.33)
5GERN Geron
62.23 M
(0.16)
 5.92 
(0.95)
6MRNA Moderna
56.31 M
(0.09)
 4.51 
(0.42)
7ROIV Roivant Sciences
51.23 M
 0.04 
 2.32 
 0.10 
8LXRX Lexicon Pharmaceuticals
41.33 M
 0.07 
 12.82 
 0.85 
9NVAX Novavax
41.03 M
(0.04)
 5.83 
(0.26)
10SANA Sana Biotechnology
40.61 M
(0.08)
 7.25 
(0.58)
11OPK Opko Health
34.96 M
(0.03)
 2.98 
(0.09)
12CHRS Coherus BioSciences
33.03 M
(0.01)
 5.74 
(0.06)
13HRTX Heron Therapeuti
32.96 M
 0.12 
 5.66 
 0.67 
14ALLO Allogene Therapeutics
32.81 M
 0.01 
 8.94 
 0.08 
15NUVB Nuvation Bio
30.81 M
 0.01 
 4.87 
 0.07 
16ARDX Ardelyx
30.19 M
 0.03 
 3.84 
 0.10 
17ESPR Esperion Therapeutics
30.03 M
(0.20)
 4.53 
(0.90)
18SGMO Sangamo Therapeutics
29.71 M
(0.08)
 6.51 
(0.54)
19NTLA Intellia Therapeutics
28.51 M
(0.02)
 5.52 
(0.10)
20LCTX Lineage Cell Therapeutics
28.43 M
(0.04)
 5.10 
(0.20)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up. If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY